NUBU Pharmaceuticals wants to produce organically grown, sustainable, medicinal cannabis products right here in New Zealand as soon as the law allows. In the meantime, NUBU will secure distribution deals to deliver high-quality medicinal cannabis products to New Zealand patients via international partners.
Delivering accessible medicinal cannabis products to New Zealanders has been the goal since the company was first proposed, and NUBU will also ensure the highest quality standards are met.
With the goal to introduce a new era of lower costs through competitive pricing and increased market accessibility, NUBU will enter into agreements with international partners to bring a range of high quality and affordable medicinal cannabis products to New Zealand patients.
With the legislation to allow the creation of a local cannabis industry imminent, the development of these products is well underway.
NUBU Pharmaceuticals goal is to produce a variety of medicinal cannabis products for New Zealand patients which will be available using a number of delivery methods.
A patient’s illness/complaint dictates the type of medicinal cannabis product that is best for them. For example, research suggests someone with Multiple Sclerosis should use a medicinal cannabis product with equal amounts of THC and CBD, while someone with Epilepsy should use a medicinal cannabis product that is CBD dominate.
It is for this reason NUBU Pharmaceutical’s plan is to create a comprehensive range of medications; some THC Dominant, some with equal parts THC & CBD and some CBD dominant.
TO THE WORLD
As well as delivering accessible medicinal cannabis products to the New Zealand market, NUBU Pharmaceuticals is working to develop this new export industry. New Zealand’s primary exports are second to none; as a country, we punch well above our weight in agriculture and horticulture and there is no reason why New Zealand can't add cannabis to that list.
As such, NUBU Pharmaceuticals is partnering with a number of our most successful exporters, and revered institutions, and implementing a plan to make the most of the opportunity that is growing and manufacturing products in New Zealand.
Development of these products is well underway, and the product pipeline is incredibly exciting.